Reichert Overview

  • Founded
  • 1905

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 131

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Reichert General Information

Description

Designer and manufacturer of diagnostic instruments and devices for ophthalmologists, optometrists, eye care professionals, life science researchers and field technicians. The company's products define eye exams and vision testing for advanced glaucoma risk analysis, non-contact air-puff tonometers as well as analysis of the composition of liquids for quality control and related purposes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Parent Company
Primary Office
  • 3362 Walden Avenue
  • Suite 100
  • Depew, NY 14043
  • United States
+1 (716) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reichert Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reichert‘s full profile, request access.

Request a free trial

Reichert Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Designer and manufacturer of diagnostic instruments and devices for ophthalmologists, optometrists, eye care professiona
Diagnostic Equipment
Depew, NY
131 As of 2021
0000 0000-00-00
000000&0

00 000

nsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000000000 000000000
Boston, MA
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reichert Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00 0000000000 Corporation Boston, MA 00000 00000000
You’re viewing 1 of 1 competitors. Get the full list »

Reichert Patents

Reichert Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220015631-A1 Single-use contact tip for tonometer Pending 17-Jul-2020 00000000
CA-3180324-A1 Flexible headrest for ophthalmic instrument Pending 09-Jun-2020 0000000000
US-11523735-B2 Flexible headrest for ophthalmic instrument Active 09-Jun-2020 0000000000 0
US-20210378503-A1 Flexible headrest for ophthalmic instrument Active 09-Jun-2020 0000000000 0
CA-3163881-A1 Positioning system for ophthalmic instrument Pending 30-Jan-2020 A61B3/0008
To view Reichert’s complete patent history, request access »

Reichert Executive Team (4)

Name Title Board Seat Contact Info
Tim Levindofske Chief Executive Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Reichert Board Members (3)

Name Representing Role Since
00000 000000 Reichert Chairman 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Reichert Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reichert Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Reichert‘s full profile, request access.

Request a free trial

Reichert Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (00 25-Jan-2006 0000000000 0000 Diagnostic Equipment 0000 0000
To view Reichert’s complete investments history, request access »